Pendrell Corporation (NasdaqGS:PCO) acquired 68.75% stake in Provitro Biosciences LLC for $16.6 million on February 21, 2013. Provitro Biosciences and its team will remain headquartered in Mt. Vernon, Washington. Jackie Heinricher will continue to serve as Chief Executive Officer and a Director of Provitro Biosciences. Pendrell does not expect the consolidation of Provitro Biosciences' existing business operations to materially affect its financial statements or cash position in the near term.


Pendrell Corporation (NasdaqGS:PCO) completed the acquisition of 68.75% stake in Provitro Biosciences LLC on February 21, 2013.